Jefferies Financial Group Inc. Takes $390,000 Position in BrightSpring Health Services, Inc. (NASDAQ:BTSG)

Jefferies Financial Group Inc. acquired a new position in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 22,925 shares of the company's stock, valued at approximately $390,000.

Other hedge funds have also recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in BrightSpring Health Services by 3.5% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 30,649 shares of the company's stock valued at $522,000 after buying an additional 1,032 shares in the last quarter. Rhumbline Advisers boosted its holdings in shares of BrightSpring Health Services by 1.5% during the 4th quarter. Rhumbline Advisers now owns 73,583 shares of the company's stock valued at $1,253,000 after acquiring an additional 1,118 shares in the last quarter. MetLife Investment Management LLC grew its position in BrightSpring Health Services by 4.9% during the 4th quarter. MetLife Investment Management LLC now owns 33,117 shares of the company's stock worth $564,000 after acquiring an additional 1,548 shares during the last quarter. Quarry LP acquired a new position in BrightSpring Health Services in the 4th quarter worth about $29,000. Finally, Legal & General Group Plc raised its position in BrightSpring Health Services by 4.8% in the fourth quarter. Legal & General Group Plc now owns 64,631 shares of the company's stock valued at $1,101,000 after purchasing an additional 2,945 shares during the last quarter.

BrightSpring Health Services Stock Performance

Shares of BTSG traded down $0.13 during mid-day trading on Wednesday, hitting $23.52. The stock had a trading volume of 467,909 shares, compared to its average volume of 1,447,753. The business has a fifty day moving average price of $19.92 and a 200-day moving average price of $19.42. BrightSpring Health Services, Inc. has a 52 week low of $10.15 and a 52 week high of $24.82. The firm has a market cap of $4.10 billion, a P/E ratio of -90.46 and a beta of 2.06. The company has a debt-to-equity ratio of 1.63, a current ratio of 1.35 and a quick ratio of 0.97.

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last issued its earnings results on Friday, May 2nd. The company reported $0.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.09 by $0.10. BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. The firm had revenue of $2.88 billion during the quarter, compared to analyst estimates of $2.74 billion. During the same quarter last year, the business earned $0.12 earnings per share. The company's quarterly revenue was up 25.9% on a year-over-year basis. On average, equities research analysts expect that BrightSpring Health Services, Inc. will post 0.59 EPS for the current year.

Analyst Ratings Changes

BTSG has been the subject of a number of recent analyst reports. Morgan Stanley increased their target price on shares of BrightSpring Health Services from $20.00 to $25.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. Wells Fargo & Company boosted their price objective on BrightSpring Health Services from $25.00 to $27.00 and gave the company an "overweight" rating in a research note on Tuesday, May 13th. Finally, Mizuho set a $26.00 price target on BrightSpring Health Services in a report on Monday, May 5th. One equities research analyst has rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, BrightSpring Health Services presently has an average rating of "Moderate Buy" and a consensus target price of $23.56.

BrightSpring Health Services Company Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.